Ovid Therapeutics Inc.
NASDAQ:OVID
1.17 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.169 | 0.148 | 0.142 | 0.109 | 0.075 | 0.066 | 0.046 | 0.011 | 0 | 1.445 | -416.349 | 0 | 0 | 208.383 | 5.703 | 6.914 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.148 | 0.136 | 0.401 | -108.863 | -74.925 | -66.094 | 0.44 | 0.415 | 0.441 | 0 | 0.057 | 0.052 | 0.053 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.021 | 0.012 | -0.26 | 108.972 | 75 | 66.16 | -0.394 | -0.404 | -0.441 | 1.445 | -416.406 | -0.052 | -0.053 | 208.383 | 5.703 | 6.914 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.124 | 0.081 | -1.835 | 1,000 | 1,000 | 1,000 | -8.506 | -36.413 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 12.479 | 10.296 | 10.541 | 5.333 | 5.999 | 6.615 | 5.545 | 5.183 | 6.047 | 7.832 | 18.09 | 4.917 | 7.684 | 16.249 | 16.884 | 15.875 | 16.033 | 14.625 | 12.105 | 11.598 | 9.117 | 9.337 | 8.622 | 8.545 | 8.116 | 8.475 | 6.713 | 5.899 | 6.075 | 31.284 | 3.991 | 2.699 | 1.77 | 1.127 | 1.139 |
| General & Administrative Expenses
| 8.104 | 7.168 | 7.689 | 6.805 | 8.248 | 8.344 | 6.674 | 7.632 | 8.257 | 9.88 | 8.263 | 6.764 | 6.629 | 15.577 | 10.411 | 7.442 | 7.109 | 5.669 | 5.163 | 5.168 | 4.205 | 4.716 | 4.505 | 4.631 | 5.093 | 4.955 | 4.335 | 3.51 | 4.213 | 2.978 | 3.598 | 3.116 | 3.646 | 2.588 | 0 |
| Selling & Marketing Expenses
| -0.045 | -0.035 | -0.301 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.059 | 7.133 | 7.388 | 6.805 | 8.248 | 8.344 | 6.674 | 7.632 | 8.257 | 9.88 | 8.263 | 6.764 | 6.629 | 15.577 | 10.411 | 7.442 | 7.109 | 5.669 | 5.163 | 5.168 | 4.205 | 4.716 | 4.505 | 4.631 | 5.093 | 4.955 | 4.335 | 3.51 | 4.213 | 2.978 | 3.598 | 3.116 | 3.646 | 2.588 | 2.209 |
| Other Expenses
| 29.038 | 5.723 | -4.076 | 0.776 | 1.764 | 1.536 | 0.668 | 0.836 | -0.284 | 0.209 | 0.004 | 0.003 | -0.003 | -0.05 | -0.438 | -0.021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 20.538 | 17.429 | 17.929 | 12.138 | 14.247 | 14.958 | 12.219 | 12.815 | 14.304 | 17.712 | 26.353 | 11.682 | 14.313 | 31.825 | 27.294 | 23.318 | 23.142 | 20.294 | 17.268 | 16.766 | 13.322 | 14.053 | 13.126 | 13.176 | 13.209 | 13.43 | 11.048 | 9.409 | 10.288 | 34.262 | 7.589 | 5.815 | 5.416 | 3.715 | 3.323 |
| Operating Income
| -20.517 | -17.417 | -18.188 | -12.029 | -14.172 | -14.892 | -12.173 | -12.804 | -14.304 | -16.267 | -26.354 | -11.682 | -14.313 | 176.557 | -27.294 | -16.404 | -23.142 | -20.294 | -17.268 | -16.766 | -13.322 | -14.054 | -13.126 | -13.176 | -13.21 | -13.43 | -11.048 | -9.409 | -10.288 | -34.262 | -7.589 | -5.815 | -5.417 | -3.714 | 0.977 |
| Operating Income Ratio
| -121.402 | -117.682 | -128.483 | -110.385 | -188.96 | -225.095 | -263.023 | -1,153.293 | 0 | -11.255 | 0.063 | 0 | 0 | 0.847 | -4.786 | -2.373 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 29.038 | 5.723 | 2.866 | 0.776 | 1.764 | 1.536 | 0.668 | 0.836 | -0.284 | 0.209 | 0.004 | 0.003 | -0.003 | -0.05 | -0.438 | -0.021 | 0.59 | 0.264 | 0.299 | 0.131 | 0.265 | 0.254 | 0.226 | 0.214 | 0.275 | 0.247 | 0.088 | 0.05 | 0.04 | 0.023 | 0.027 | 0.03 | 0.032 | 0.032 | -4.27 |
| Income Before Tax
| 8.521 | -11.694 | -15.322 | -11.252 | -12.408 | -13.356 | -11.505 | -11.968 | -14.588 | -16.058 | -26.35 | -11.679 | -14.315 | 176.508 | -22.03 | -16.425 | -22.551 | -20.03 | -16.969 | -16.635 | -13.057 | -13.8 | -12.9 | -12.962 | -12.935 | -13.183 | -10.96 | -9.359 | -10.248 | -34.239 | -7.561 | -5.785 | -5.386 | -3.682 | -3.293 |
| Income Before Tax Ratio
| 50.42 | -79.014 | -108.236 | -103.259 | -165.444 | -201.877 | -248.586 | -1,077.983 | 0 | -11.11 | 0.063 | 0 | 0 | 0.847 | -3.863 | -2.376 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.093 | -0 | 0 | 0 | -1,536.096 | -0.05 | -0.836 | 0.285 | 0.05 | -0.35 | -0.295 | 1.473 | 0.5 | 0 | 0 | -0.001 | 0 | -0 | 0 | 0 | 0 | -0.001 | 0 | 0.001 | 0.001 | 0 | -0.001 | -0.019 | -0 | -0 | 0 | 0.001 | -0 | 0 |
| Net Income
| 8.521 | -11.694 | -15.322 | -11.252 | -12.408 | 1,522.74 | -11.455 | -11.131 | -14.873 | -16.108 | -26 | -11.384 | -15.788 | 176.007 | -22.03 | -16.425 | -22.551 | -20.03 | -16.969 | -16.635 | -13.057 | -13.8 | -12.9 | -12.962 | -12.935 | -13.183 | -10.96 | -9.359 | -10.248 | -34.239 | -7.561 | -5.785 | -5.386 | -3.682 | -3.293 |
| Net Income Ratio
| 50.42 | -79.014 | -108.236 | -103.259 | -165.444 | 23,016 | -247.506 | -1,002.647 | 0 | -11.145 | 0.062 | 0 | 0 | 0.845 | -3.863 | -2.376 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.12 | -0.17 | -0.22 | -0.16 | -0.18 | 21.6 | -0.16 | -0.16 | -0.21 | -0.23 | -0.39 | -0.17 | -0.23 | 2.55 | -0.35 | -0.28 | -0.41 | -0.37 | -0.35 | -0.43 | -0.34 | -0.46 | -0.52 | -0.53 | -0.53 | -0.54 | -0.45 | -0.38 | -0.57 | -1.39 | -0.39 | -0.3 | -0.27 | -0.19 | -0.33 |
| EPS Diluted
| 0.12 | -0.17 | -0.22 | -0.16 | -0.18 | 21.6 | -0.16 | -0.16 | -0.21 | -0.23 | -0.38 | -0.17 | -0.23 | 2.53 | -0.34 | -0.28 | -0.41 | -0.37 | -0.35 | -0.43 | -0.34 | -0.46 | -0.52 | -0.53 | -0.53 | -0.54 | -0.45 | -0.38 | -0.57 | -1.39 | -0.39 | -0.3 | -0.27 | -0.19 | -0.33 |
| EBITDA
| -20.369 | -17.281 | -17.787 | -11.626 | -13.777 | -14.892 | -12.173 | -12.389 | -13.851 | -16.193 | -26.296 | -11.63 | -14.26 | 176.632 | -21.591 | -16.325 | -23.064 | -20.228 | -17.268 | -16.71 | -13.253 | -13.977 | -13.126 | -13.141 | -13.184 | -13.403 | -11.048 | -9.388 | -10.288 | -34.244 | -7.556 | -5.806 | -5.408 | -3.709 | 0.979 |
| EBITDA Ratio
| -120.527 | -116.764 | -125.648 | -106.689 | -183.693 | -225.095 | -263.023 | -1,115.906 | 0 | -11.203 | 0.063 | 0 | 0 | 0.848 | -3.786 | -2.361 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |